MCM
CYTXW

Manchester Capital Management’s Cytori Therapeutics Inc Warrant CYTXW Stock Holding History

Manchester Capital Management’s Portfolio CYTXW Stock Details CYTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7
Closed – – 538
2018
Q3 		$0 Hold
7
– – ﹤0.01% 541
2018
Q2 		$0 Hold
7
– – ﹤0.01% 615
2018
Q1 		$0 Buy
+7
New – ﹤0.01% 606
2017
Q4 		– Sell
-7
Closed – – 516
2017
Q3 		$0 Buy
+7
New +$1 ﹤0.01% 503
2017
Q2 		– Sell
-7
Closed – – 512
2017
Q1 		$0 Buy
+7
New +$5 ﹤0.01% 517
2016
Q4 		– Sell
-7
Closed – – 527
2016
Q3 		$0 Hold
7
– – ﹤0.01% 540
2016
Q2 		$0 Buy
+7
New +$5 ﹤0.01% 603

Manchester Capital Management's CYTXW Position: Q4 2018 in Review

Manchester Capital Management sold out of Cytori Therapeutics Inc Warrant (CYTXW) in Q4 2018, closing a stake of 7 shares.

Manchester Capital Management first reported a position in CYTXW in Q2 2016 and held it in 7 quarters. The position peaked at $0 in Q3 2018. 0 funds tracked by Wall St. Rank hold CYTXW as of Q4 2018.

  • Manchester Capital Management reported no remaining Cytori Therapeutics Inc Warrant position as of Q4 2018 after selling out during the quarter.
  • Manchester Capital Management sold 7 Cytori Therapeutics Inc Warrant shares in Q4 2018.
  • Manchester Capital Management first reported a position in Cytori Therapeutics Inc Warrant in Q2 2016 and held it in 7 quarters.
  • Manchester Capital Management's Cytori Therapeutics Inc Warrant position peaked at $0 in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Warrant as of Q4 2018.

Based on Manchester Capital Management's 13F filing for Q4 2018, filed 4 Feb 2019.